Pathophysiology of anthrax
- PMID: 19273366
- PMCID: PMC4109055
- DOI: 10.2741/3544
Pathophysiology of anthrax
Abstract
Infection by Bacillus anthracis in animals and humans results from accidental or intentional exposure, by oral, cutaneous or pulmonary routes, to spores, which are normally present in the soil. Treatment includes administration of antibiotics, vaccination or treatment with antibody to the toxin. A better understanding of the molecular basis of the processes involved in the pathogenesis of anthrax namely, spore germination in macrophages and biological effects of the secreted toxins on heart and blood vessels will lead to improved management of infected animals and patients. Controlling germination will be feasible by inhibiting macrophage paralysis and cell death. On the other hand, the control of terminal hypotension might be achieved by inhibition of cardiomyocyte mitogen-activated protein kinase and stimulation of vessel cAMP.
Figures







References
-
- Sternbach G. The history of anthrax. J Emerg Med. 2003;24:463–467. - PubMed
-
- Wenner KA, Kenner JR. Anthrax. Dermatol Clin. 2004;22:247–256. - PubMed
-
- Kasten FH. Biological weapons, war crimes, and WWI. Science. 2002;296:1235–1237. - PubMed
-
- Steichen CT, Kearney JF, Turnbough CL. Non-uniform assembly of the Bacillus anthracis exosporium and a bottle cap model for spore germination and outgrowth. Mol Microbiol. 2007;64:359–367. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources